Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
about
Nanocarriers Usage for Drug Delivery in Cancer TherapyThe preparation of metal-organic frameworks and their biomedical applicationEngineered nanomaterial uptake and tissue distribution: from cell to organismSizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.Can nanotechnology potentiate photodynamic therapy?Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA)Mechanisms and implications of air pollution particle associations with chemokinesMechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro StudiesHow stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements.Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.Novel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles.Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)Cancer targeted therapeutics: From molecules to drug delivery vehicles.Growth of arrays of oriented epitaxial platinum nanoparticles with controlled size and shape by natural colloidal lithographyCapillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment.Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system.High-sensitivity in vivo imaging for tumors using a spectral up-conversion nanoparticle NaYF4: Yb3+, Er3+ in cooperation with a microtubulin inhibitor.Shining light on nanotechnology to help repair and regeneration.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Packaging biological cargoes in mesoporous materials: opportunities for drug deliveryBiologically optimized nanosized molecules and particles: more than just size.Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals.Fabrication of poly(γ-glutamic acid)-based biopolymer as the targeted drug delivery system with enhanced cytotoxicity to APN/CD13 over-expressed cells.BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancerBioimaging of Hyaluronate-Interferon α Conjugates Using a Non-Interfering Zwitterionic FluorophoreVIP-targeted Cytotoxic Nanomedicine for Breast CancerTargeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriersSize-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cellsSolid-state characterization studies and effect of PEG 20000 and P90G on particle size reduction and stability of complexed glimepiride nanocrystals.Nanotechnology in medical imaging: probe design and applications.In vivo and in vitro evaluation of octyl methoxycinnamate liposomesBacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying PotentialIn vivo biodistribution of iron oxide nanoparticles: an overview.Accumulation of nano-sized particles in a murine model of angiogenesis.
P2860
Q26740048-E0DE754F-4D09-49AB-B3EB-8EFB03999F0DQ26752872-D1135DFF-689F-4770-83EA-89F08B502F1CQ26861914-29621893-AB92-484E-A43A-7E8895D463B4Q27324846-7A40DA8C-D3BB-45E7-A67B-1D1537ED1E92Q28388084-7A26ECBC-CEB4-4BB8-8D10-5BC0B6394389Q28392648-2FE54BBF-270D-45EF-A602-6E0ECE51AA10Q28756508-416152E3-DE72-4F1A-BBEE-0681E6569CC9Q29248759-F7D05314-89DB-4DFE-B571-362A92B2476AQ30318410-D0CA643E-9E6F-45CF-993F-4A7BA0A4EB3FQ30481085-B0D771D4-9D81-476A-BEB3-0BD59852D0B5Q30585395-5DECF920-7DA2-43E5-A8EB-CE7D5A78B8F6Q33487116-F93220A9-538B-432F-8957-AB74BF4DE57BQ33719218-FBBCD356-54F0-4137-85EF-B41D744EEEDAQ33887986-8018C13C-68E0-459D-A897-4A19FDBE4F6AQ33935717-0396BB66-6B91-4BE6-A2E7-4FADFBD4B0EFQ34052540-0F46B7A1-E61B-4B37-B89E-2BFB571A1677Q34088052-3DF50591-679C-4DE8-A14A-093EF9E762F4Q34288315-F90B6FD8-B41C-4EEA-A1A9-07BCDDE0125AQ34404413-FDA0EBD4-3119-4EE6-AF96-1659C9E482DAQ34534023-8A5D46C1-7F46-4409-9C2A-CF137EBE9F0AQ34576316-A515B878-94EB-4E92-993C-F22C06D193FBQ35048175-74F18FC8-C479-494C-A835-42375EF7F8F5Q35071594-9405EF6B-7B5D-4DFB-8645-777CA3C759D2Q35231632-602D90E6-2BFF-48FA-AB0D-EDCEF0CA5AE7Q35554484-BBF9889D-50C9-4DCA-A38F-EBF56B06E44EQ35673015-99ACF993-D204-4DBC-9B4B-547F3E440B7AQ35970627-F5D03306-0325-43CF-A12C-4B6F4691A4B8Q36155858-DCE620D8-3698-4C47-9C83-62AD127AABEFQ36538910-BBE5B4DA-8E78-4F39-881F-8BABE14191D2Q36589179-D463992A-9F0B-449A-92BF-8C9D85DD1299Q36590092-BB8C303D-654B-4B3B-81B5-80870EBE5CF6Q36721737-4264A5AC-DD83-4EC3-BDBA-7F40F128AB09Q36831931-A6DF404C-2A65-4947-9888-435DAF0213CCQ37152401-1EBC799D-843E-486C-9613-5C4AAC21997BQ37267676-24A2E41E-4F3D-4606-B9FB-3F83E6B1980FQ37341362-05C1FBAB-8DBF-49E7-808D-339CBE82E38FQ37396564-CD7D669C-9E0A-4D23-8EFC-4EA7C0A3FA39Q37436787-6A6B4347-E92E-4950-BB82-00F9C1EE8F48Q37519836-03280928-36B5-4422-A8D6-1CEA040F980FQ37540993-AE2DDC8A-5285-43A7-99B7-E95A07963FF6
P2860
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nanoparticles for drug deliver ...... ting particle size parameters.
@en
type
label
Nanoparticles for drug deliver ...... ting particle size parameters.
@en
prefLabel
Nanoparticles for drug deliver ...... ting particle size parameters.
@en
P2093
P1476
Nanoparticles for drug deliver ...... ting particle size parameters.
@en
P2093
Angelica Vargas
Florence Delie
Marie Gaumet
Robert Gurny
P356
10.1016/J.EJPB.2007.08.001
P407
P577
2007-08-07T00:00:00Z